Advances in Hematological Malignancies
Recent centuries have witnessed remarkable strides in the domain of hematological malignancies. Novel approaches such as targeted drugs, immunotherapies, and gene editing here are revolutionizing the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative techniques, offering potential for more cu